M. Lohse, K. Klotz, J. Lindenborn-Fotinos, M. Reddington, U. Schwabe, and R. Olsson. Naunyn Schmiedebergs Arch Pharmacol, 336 (2):
204-10(August 1987)Lohse, M J Klotz, K N Lindenborn-Fotinos, J Reddington, M Schwabe,
U Olsson, R A HL-30391/HL/NHLBI NIH HHS/United States Comparative
Study In Vitro Research Support, Non-U.S. Gov't Research Support,
U.S. Gov't, P.H.S. Germany, west Naunyn-Schmiedeberg's archives of
pharmacology Naunyn Schmiedebergs Arch Pharmacol. 1987 Aug;336(2):204-10..
H. von der Leyen, W. Schmitz, H. Scholz, J. Scholz, M. Lohse, and U. Schwabe. Naunyn Schmiedebergs Arch Pharmacol, 340 (2):
204-9(August 1989)von der Leyen, H Schmitz, W Scholz, H Scholz, J Lohse, M J Schwabe,
U In Vitro Research Support, Non-U.S. Gov't Germany, west Naunyn-Schmiedeberg's
archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol. 1989
Aug;340(2):204-9..
U. Schwabe, D. Ukena, and M. Lohse. Naunyn Schmiedebergs Arch Pharmacol, 330 (3):
212-21(September 1985)Schwabe, U Ukena, D Lohse, M J In Vitro Research Support, Non-U.S.
Gov't Germany, west Naunyn-Schmiedeberg's archives of pharmacology
Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):212-21..
M. Reddington, K. Klotz, M. Lohse, and B. Hietel. FEBS Lett, 252 (1-2):
125-8(July 1989)Reddington, M Klotz, K N Lohse, M J Hietel, B Research Support, Non-U.S.
Gov't Netherlands FEBS letters FEBS Lett. 1989 Jul 31;252(1-2):125-8..